Emicizumab (Anti-Factor IX & Factor X)
Emicizumab is a recombinant, humanized, bispecific antibody that binds Factor IXa and Factor X to mimic Factor VIII function. It is used to treat hemophilia A. M.W 146.82 kDa
| Trivial name | ACE910 |
| Catalog Number | A4061 |
| CAS# | 1610943-06-0 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/emicizumab.html |